VP
Valeo Pharma Inc.
VPHIF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $13.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/FFO N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 93.25%
FCF growth N/A
Book val. growth N/A
Profitability
8 /100
Weak Net margin 51.58%
Op. margin 31.96%
FCF margin 39.41%
Quality
21 /100
Poor ROA 67.48%
Asset turnover 1.31x
ROIC 67.29%
Debt
23 /100
High Int. coverage -1.02x
Current ratio 1.25x
Net debt/EBITDA N/A
Stability
54 /100
Moderate Rev. volatility 11.61%
EPS volatility 71.97%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o VPHIF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kyle Steiger
Employees
70
Headquarters
Kirkland
Nadchodzące wydarzenia
30 GRU
Earnings
Upcoming earnings report